LLY
916.07
-0.02%↓
UNH
566.13
-0.87%↓
NVO
118.17
+0.23%↑
JNJ
164.55
+0.16%↑
ABBV
188.57
-1%↓
LLY
916.07
-0.02%↓
UNH
566.13
-0.87%↓
NVO
118.17
+0.23%↑
JNJ
164.55
+0.16%↑
ABBV
188.57
-1%↓
LLY
916.07
-0.02%↓
UNH
566.13
-0.87%↓
NVO
118.17
+0.23%↑
JNJ
164.55
+0.16%↑
ABBV
188.57
-1%↓
LLY
916.07
-0.02%↓
UNH
566.13
-0.87%↓
NVO
118.17
+0.23%↑
JNJ
164.55
+0.16%↑
ABBV
188.57
-1%↓
LLY
916.07
-0.02%↓
UNH
566.13
-0.87%↓
NVO
118.17
+0.23%↑
JNJ
164.55
+0.16%↑
ABBV
188.57
-1%↓
Übersicht
Veränderung der Aktienkurses
24h
Aktuell
Min
Max
Empfehlungen | Buy |
---|---|
12-Monats-Prognose | +532.91 upside |
AcelRx Pharmaceuticals Inc Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
17. Okt. 2024, 23:57 UTC
Stocks to Watch: Netflix, MGP Ingredients, Bausch Health
DJ
Lesen
17. Okt. 2024, 22:35 UTC
SLB to Sell Interest in Palliser Block in Canada
DJ
Lesen
17. Okt. 2024, 21:33 UTC
Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat
DJ
Lesen
17. Okt. 2024, 20:56 UTC
Intuitive Surgical Posts 3Q Revenue Growth
DJ
Lesen
17. Okt. 2024, 23:51 UTC
BHP Unlikely to Quickly Approach Anglo American Again, Says Bull -- Market Talk
DJ
Lesen
17. Okt. 2024, 23:22 UTC
Amex Earnings Will Test Stock's Rally. Revenue Is the Focus. -- Barrons.com
DJ
Lesen
17. Okt. 2024, 23:14 UTC
Netflix Subscriber Growth Slows Amid Revenue Gains -- 4th Update
DJ
Lesen
17. Okt. 2024, 22:56 UTC
Santos's Balance Sheet Risks to Ease From Here -- Market Talk
DJ
Lesen
17. Okt. 2024, 22:52 UTC
Santos's Upcoming Investor Day Likely Positive -- Market Talk
DJ
Lesen
17. Okt. 2024, 22:32 UTC
De Grey Runs Into Delay on Hemi Permitting, But Approval Likely -- Market Talk
DJ
Lesen
17. Okt. 2024, 22:23 UTC
Nike Outlook Revised on Unclear Outcome of Turnaround Strategy -- Market Talk
DJ
Lesen
17. Okt. 2024, 22:13 UTC
Global Equities Roundup: Market Talk
DJ
Lesen
17. Okt. 2024, 22:13 UTC
Netflix Isn't Interested in Bundling With Other Streaming Services -- Market Talk
DJ
Lesen
17. Okt. 2024, 21:57 UTC
Netflix Subscriber Growth Slows Amid Revenue Gains -- 3rd Update
DJ
Lesen
17. Okt. 2024, 21:48 UTC
SLB: Palliser Block Consists of Oil and Gas Wells, Surface Facilities, a Pipeline Network and Certain Oil and Gas Development Rights >SLB
DJ
Lesen
17. Okt. 2024, 21:48 UTC
SLB: Transaction Is Expected to Close Late in the 4Q >SLB
DJ
Lesen
17. Okt. 2024, 21:48 UTC
SLB: Announces Definitive Agreement to Sell Its Interests in Palliser Block
DJ
Lesen
17. Okt. 2024, 21:32 UTC
Netflix's Release Schedule Should be 'Largely Back to Normal' in 2025 -- Market Talk
DJ
Lesen
17. Okt. 2024, 21:25 UTC
Google Executive Overseeing Search and Advertising Leaves Role -- 2nd Update
DJ
Lesen
17. Okt. 2024, 21:21 UTC
Netflix Says It Will Double Revenue from Advertising in FY25 -- Market Talk
DJ
Lesen
17. Okt. 2024, 21:18 UTC
Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat
DJ
Lesen
17. Okt. 2024, 21:10 UTC
Lucid Stock Tumbles 18%. EV Maker Plans Huge Share Sale, Sees Wider Losses. -- Barrons.com
DJ
Lesen
17. Okt. 2024, 21:03 UTC
CSX, Canadian Pacific Kansas City, Genesee & Wyoming: Surface Transportation Board Approves CSX, CPKC Respective Applications Regarding Acquisition of Rail Lines Operated by G&W's Meridian & Bigbee Railroad
DJ
Lesen
17. Okt. 2024, 20:55 UTC
Netflix Clobbers Third-Quarter Estimates, Guides Above Views -- IBD
DJ
Lesen
17. Okt. 2024, 20:55 UTC
Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Going Up Across the World. -- Barrons.com
DJ
Lesen
17. Okt. 2024, 20:50 UTC
Netflix Stock Jumps on a Strong Outlook for Profit Margin. Prices Are Growing Up Across the World. -- Barrons.com
DJ
Lesen
17. Okt. 2024, 20:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Lesen
17. Okt. 2024, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lesen
17. Okt. 2024, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lesen
17. Okt. 2024, 20:49 UTC
Netflix Subscriber Growth Slows Amid Revenue Gains -- 2nd Update
DJ
Lesen
Peer-Vergleich
Kursveränderung
AcelRx Pharmaceuticals Inc Prognose
Kursziel
By TipRanks
12-Monats-Prognose
Durchschnitt 5 USD 532.91%
Hoch 5 USD
Tief 5 USD
Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AcelRx Pharmaceuticals Inc – Dist angeboten haben.
Rating-Konsens
By TipRanks
Buy
1 ratings
1
Buy
0
Halten
0
Sell
Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für AcelRx Pharmaceuticals Inc – Dist abgegeben haben.
Finanzen
$